InvestorsHub Logo
Followers 195
Posts 24733
Boards Moderated 0
Alias Born 04/03/2010

Re: eagle8 post# 461765

Friday, 04/22/2022 8:46:34 AM

Friday, April 22, 2022 8:46:34 AM

Post# of 704127
I don’t think Merck sees it as a “risk”, but I agree that, absent any unexpected problems with the trial, basically DCVax-L wins in almost any outcome. This assumes good results like we saw in the interim phase 3 analysis or better.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News